Mortality attributable to Plasmodium vivax malaria: A clinical audit from Papua, Indonesia

BMC Medicine

Volumn 12, Issue 1, 2014, Pages

  Douglas, Nicholas M ^a,b   Pontororing, Gysje J ^c   Lampah, Daniel A ^c   Yeo, Tsin W ^a   Kenangalem, Enny ^c,d   Poespoprodjo, Rini ^c,d,e   Ralph, Anna P ^a,f   Bangs, Michael J ^g,h   Sugiarto, Paulus ⁱ   Anstey, Nicholas M ^a,f   Price, Ric N ^a,b  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c Papuan Health and Community Development Foundation   (Indonesia)

^d District Health Authority   (Indonesia)

^e GADJAH MADA UNIVERSITY   (Indonesia)

^f ROYAL DARWIN HOSPITAL   (Australia)

^g Public Health and Malaria Control Department Papua   (Indonesia)

^h KASETSART UNIVERSITY   (Thailand)

ⁱ Mitra Masyarakat Hospital Indonesia   (Indonesia)

Author keywords

Indonesia; Malaria; Mortality; Papua; Plasmodium; vivax

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANEMIA; ARTICLE; BACTERIAL MENINGITIS; BRAIN MALARIA; CAUSE OF DEATH; CHILD; CHRONIC DISEASE; COMA; FATALITY; FEMALE; GASTROINTESTINAL SYMPTOM; HOSPITAL PATIENT; HUMAN; INDONESIA; INFANT; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MALNUTRITION; MEDICAL AUDIT; MIDDLE AGED; MIXED INFECTION; MORTALITY; PARASITEMIA; PLASMODIUM VIVAX MALARIA; PRESCHOOL CHILD; RESPIRATORY DISTRESS; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; SEPSIS; TERTIARY CARE CENTER; YOUNG ADULT; AGED; COMPLICATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALARIA, VIVAX; PLASMODIUM VIVAX; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CLINICAL AUDIT; FEMALE; HIV INFECTIONS; HUMANS; INDONESIA; INFANT; MALARIA, VIVAX; MALE; MIDDLE AGED; PLASMODIUM VIVAX; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES;

EID: 84924297690     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/s12916-014-0217-z     Document Type: Article

References (42)

1. Guerra CA, Howes RE, Patil AP, Gething PW, Van Boeckel TP, Temperley WH, Kabaria CW, Tatem AJ, Manh BH, Elyazar IR, Baird JK, Snow RW, Hay SI: The international limits and population at risk of Plasmodium vivax transmission in 2009. PLoS Negl Trop Dis 2010, 4:e774.
2. Gething PW, Elyazar IR, Moyes CL, Smith DL, Battle KE, Guerra CA, Patil AP, Tatem AJ, Howes RE, Myers MF, George DB, Horby P, Wertheim HF, Price RN, Müeller I, Baird JK, Hay SI: A long neglected world malaria map: Plasmodium vivax endemicity in 2010. PLoS Negl Trop Dis 2012, 6:e1814.
3. Douglas NM, Lampah DA, Kenangalem E, Simpson JA, Poespoprodjo JR, Sugiarto P, Anstey NM, Price RN: Major burden of severe anemia from non-falciparum malaria species in Southern Papua: a hospital-based surveillance study. PLoS Med 2013, 10:e1001575.
4. Poespoprodjo JR, Fobia W, Kenangalem E, Lampah DA, Warikar N, Seal A, McGready R, Sugiarto P, Tjitra E, Anstey NM, Price RN: Adverse pregnancy outcomes in an area where multidrug-resistant plasmodium vivax and Plasmodium falciparum infections are endemic. Clin Infect Dis 2008, 46:1374-1381.
5. McGready R, Lee SJ, Wiladphaingern J, Ashley EA, Rijken MJ, Boel M, Simpson JA, Paw MK, Pimanpanarak M, Mu O, Singhasivanon P, White NJ, Nosten FH: Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study. Lancet Infect Dis 2012, 12:388-396.
6. Baird JK: Evidence and implications of mortality associated with acute Plasmodium vivax malaria. Clin Microbiol Rev 2013, 26:36-57.
7. Price RN, Douglas NM, Anstey NM: New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance. Curr Opin Infect Dis 2009, 22:430-435.
8. Barcus MJ, Basri H, Picarima H, Manyakori C: Sekartuti, Elyazar I, Bangs MJ, Maguire JD, Baird JK: Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions in northeastern Indonesian Papua. Am J Trop Med Hyg 2007, 77:984-991.
9. Rodriguez-Morales AJ, Benitez JA, Arria M: Malaria mortality in Venezuela: focus on deaths due to plasmodium vivax in children. J Trop Pediatr 2008, 54:94-101.
10. Tjitra E, Anstey NM, Sugiarto P, Warikar N, Kenangalem E, Karyana M, Lampah DA, Price RN: Multidrug-resistant plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua. Indonesia. PLoS Med 2008, 5:e128.
11. Lacerda MV, Fragoso SC, Alecrim MG, Alexandre MA, Magalhaes BM, Siqueira AM, Ferreira LC, Araujo JR, Mourao MP, Ferrer M, Castillo P, Martin-Jaular L, Fernandez-Becerra C, del Portillo H, Ordi J, Alonso PL, Bassat Q: Postmortem characterization of patients with clinical diagnosis of Plasmodium vivax malaria: to what extent does this parasite kill? Clin Infect Dis 2012, 55:e67-e74.
12. Ratcliff A, Siswantoro H, Kenangalem E, Maristela R, Wuwung RM, Laihad F, Ebsworth EP, Anstey NM, Tjitra E, Price RN: Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison. Lancet 2007, 369:757-765.
13. Karyana M, Burdarm L, Yeung S, Kenangalem E, Wariker N, Maristela R, Umana KG, Vemuri R, Okoseray MJ, Penttinen PM, Ebsworth P, Sugiarto P, Anstey NM, Tjitra E, Price RN: Malaria morbidity in Papua Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium falciparum. Malar J 2008, 7:148.
14. Randall LM, Kenangalem E, Lampah DA, Tjitra E, Mwaikambo ED, Handojo T, Piera KA, Zhao ZZ, de Labastida Rivera F, Zhou Y, McSweeney KM, Le L, Amante FH, Haque A, Stanley AC, Woodberry T, Salwati E, Granger DL, Hobbs MR, Price RN, Weinberg JB, Montgomery GW, Anstey NM, Engwerda CR: Age-related susceptibility to severe malaria associated with galectin-2 in highland Papuans. J Infect Dis 2010, 202:117-124.
15. Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg 2000, 94:S1-S90.
16. Anstey NM, Douglas NM, Poespoprodjo JR, Price RN: Plasmodium vivax: clinical spectrum, risk factors and pathogenesis. Adv Parasitol 2012, 80:151-201.
17. Dipchand AI: The HSC Handbook of Pediatrics. 9th edition. St Louis: Mosby; 1997.
18. Lee G, Yori P, Olortegui MP, Pan W, Caulfield L, Gilman RH, Sanders JW, Delgado HS, Kosek M: Comparative effects of vivax malaria, fever and diarrhoea on child growth. Int J Epidemiol 2012, 41:531-539.
19. The WHO Child Growth Standards. [http://www.who.int/childgrowth/en/]
20. Rodriguez-Morales AJ, Sanchez E, Vargas M, Piccolo C, Colina R, Arria M, Franco-Paredes C: Is anemia in Plasmodium vivax malaria more frequent and severe than in Plasmodium falciparum? Am J Med 2006, 119:e9-e10.
21. Poespoprodjo JR, Fobia W, Kenangalem E, Lampah DA, Hasanuddin A, Warikar N, Sugiarto P, Tjitra E, Anstey NM, Price RN: Vivax malaria: a major cause of morbidity in early infancy. Clin Infect Dis 2009, 48:1704-1712.
22. Kitchen SF: Malariology. London: W. B. Saunders & Co.; 1939.
23. Hutchinson RA, Lindsay SW: Malaria and deaths in the English marshes. Lancet 2006, 367:1947-1951.
24. Williams TN, Maitland K, Phelps L, Bennett S, Peto TE, Viji J, Timothy R, Clegg JB, Weatherall DJ, Bowden DK: Plasmodium vivax: a cause of malnutrition in young children. QJM 1997, 90:751-757.
25. Lanca EF, Magalhaes BM, Vitor-Silva S, Siqueira AM, Benzecry SG, Alexandre MA, O'Brien C, Bassat Q, Lacerda MV: Risk factors and characterization of Plasmodium vivax-associated admissions to pediatric intensive care units in the Brazilian Amazon. PLoS One 2012, 7:e35406.
26. Berkley JA, Bejon P, Mwangi T, Gwer S, Maitland K, Williams TN, Mohammed S, Osier F, Kinyanjui S, Fegan G, Lowe BS, English M, Peshu N, Marsh K, Newton CR: HIV infection, malnutrition, and invasive bacterial infection among children with severe malaria. Clin Infect Dis 2009, 49:336-343.
27. Anstey NM, Handojo T, Pain MC, Kenangalem E, Tjitra E, Price RN, Maguire GP: Lung injury in vivax malaria: pathophysiological evidence for pulmonary vascular sequestration and posttreatment alveolar-capillary inflammation. J Infect Dis 2007, 195:589-596.
28. Tan LK, Yacoub S, Scott S, Bhagani S, Jacobs M: Acute lung injury and other serious complications of Plasmodium vivax malaria. Lancet Infect Dis 2008, 8:449-454.
29. Price L, Planche T, Rayner C, Krishna S: Acute respiratory distress syndrome in Plasmodium vivax malaria: case report and review of the literature. Trans R Soc Trop Med Hyg 2007, 101:655-659.
30. Taylor WR, Hanson J, Turner GD, White NJ, Dondorp AM: Respiratory manifestations of malaria. Chest 2012, 142:492-505.
31. Bronzan RN, Taylor TE, Mwenechanya J, Tembo M, Kayira K, Bwanaisa L, Njobvu A, Kondowe W, Chalira C, Walsh AL, Phiri A, Wilson LK, Molyneux ME, Graham SM: Bacteremia in Malawian children with severe malaria: prevalence, etiology, HIV coinfection, and outcome. J Infect Dis 2007, 195:895-904.
32. Berkley JA, Mwangi I, Mellington F, Mwarumba S, Marsh K: Cerebral malaria versus bacterial meningitis in children with impaired consciousness. QJM 1999, 92:151-157.
33. Gwer S, Newton CR, Berkley JA: Over-diagnosis and co-morbidity of severe malaria in African children: a guide for clinicians. Am J Trop Med Hyg 2007, 77:6-13.
34. Genton B, D'Acremont V, Rare L, Baea K, Reeder JC, Alpers MP, Muller I: Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. PLoS Med 2008, 5:e127.
35. Andrade BB, Reis-Filho A, Souza-Neto SM, Clarencio J, Camargo LM, Barral A, Barral-Netto M: Severe Plasmodium vivax malaria exhibits marked inflammatory imbalance. Malar J 2010, 9:13.
36. Yeo TW, Lampah DA, Tjitra E, Piera K, Gitawati R, Kenangalem E, Price RN, Anstey NM: Greater endothelial activation, Weibel-Palade body release and host inflammatory response to Plasmodium vivax, compared with Plasmodium falciparum: a prospective study in Papua, Indonesia. J Infect Dis 2010, 202:109-112.
37. Bhattacharya SK, Sur D, Dutta S, Kanungo S, Ochiai RL, Kim DR, Anstey NM, von Seidlein L, Deen J: Vivax malaria and bacteraemia: a prospective study in Kolkata. India Malar J 2013, 12:176.
38. Bejon P, Berkley JA, Mwangi T, Ogada E, Mwangi I, Maitland K, Williams T, Scott JA, English M, Lowe BS, Peshu N, Newton CR, Marsh K: Defining childhood severe falciparum malaria for intervention studies. PLoS Med 2007, 4:e251.
39. Pontororing GJ, Kenangalem E, Lolong DB, Waramori G, Sandjaja, Tjitra E, Price RN, Kelly PM, Anstey NM, Ralph AP, Sandjaja SS, Tjitra E, Price RN, Kelly PM, Anstey NM, Ralph AP: The burden and treatment of HIV in tuberculosis patients in Papua Province, Indonesia: a prospective observational study. BMC Infect Dis 2010, 10:362.
40. Swarthout TD, Counihan H, Senga RK, van den Broek I: Paracheck-Pf accuracy and recently treated Plasmodium falciparum infections: is there a risk of over-diagnosis? Malar J 2007, 6:58.
41. Siripoon N, Snounou G, Yamogkul P, Na-Bangchang K, Thaithong S: Cryptic Plasmodium falciparum parasites in clinical P. vivax blood samples from Thailand. Trans R Soc Trop Med Hyg 2002, 96:70-71.
42. Barber BE, William T, Grigg MJ, Parameswaran U, Piera KA, Price RN, Yeo TW, Anstey NM: Parasite Biomass-Related Inflammation, and Endothelial Activation, Microvascular Dysfunction and Disease Severity in Vivax Malaria. PLoS Pathogens, in Press 2014.